Literature DB >> 18007164

Understanding the gap between good processes of diabetes care and poor intermediate outcomes: Translating Research into Action for Diabetes (TRIAD).

Joe V Selby1, Bix E Swain, Robert B Gerzoff, Andrew J Karter, Beth E Waitzfelder, Arleen F Brown, Ronald T Ackermann, O Kenrik Duru, Assiamira Ferrara, William Herman, David G Marrero, Dorothy Caputo, K M Venkat Narayan.   

Abstract

BACKGROUND: Performance of diabetes clinical care processes has improved recently, but control of hemoglobin A1c (A1c) and other vascular disease risk factors has improved more slowly.
OBJECTIVES: To identify patient factors associated with control of vascular disease risk factors among diabetes patients receiving recommended care processes. POPULATION: Managed care enrollees who participated in the TRIAD (Translating Research into Action for Diabetes) Study and received at least 5 of 7 recommended care processes during the 12 months before the second survey (2002-2003).
METHODS: Comparison of 1003 patients with good control of A1c (<8%), systolic blood pressure (<140 mm Hg) and LDL-cholesterol (<130 mg/dL) versus 812 patients with poor control for at least 2 of these factors.
RESULTS: Poorly controlled patients were younger, more frequently female, African American, with lower education and income (P < 0.001 for each). General health status was lower, body mass index higher, and insulin treatment more frequent; history of prior coronary heart disease was less frequent. They were more likely to indicate depression and hopelessness and to identify costs as a barrier to self-care; less likely to report trust in their regular physician; and more likely to smoke cigarettes and be physically inactive. Adjusting for demographic and clinical variables, concerns about costs, low trust in one's physician, current smoking, and physical inactivity remained associated with poor control. However, inclusion of these 4 variables in a single model did not diminish associations of race/ethnicity or education with control.
CONCLUSIONS: Clinical, socioeconomic, psychosocial, and behavioral factors were independently associated with poor control. However, these factors did not fully explain observed racial and socioeconomic disparities in control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18007164     DOI: 10.1097/MLR.0b013e3181468e79

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  27 in total

1.  Breakout session: Ethnic and gender differences in diabetic foot management and amputations.

Authors:  Anthony E Johnson; Carlos Lavernia
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

2.  The relation between health insurance and health care disparities among adults with disabilities.

Authors:  Nancy A Miller; Adele Kirk; Michael J Kaiser; Lukas Glos
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

3.  Is the physical functioning of older adults with diabetes associated with the processes and outcomes of care? Evidence from Translating Research Into Action for Diabetes (TRIAD).

Authors:  P G Lee; L N McEwen; B Waitzfelder; U Subramanian; A J Karter; C M Mangione; W H Herman
Journal:  Diabet Med       Date:  2012-09       Impact factor: 4.359

4.  Systematic review and meta-analysis of patient race/ethnicity, socioeconomics, and quality for adult type 2 diabetes.

Authors:  Woolton Lee; Jennifer T Lloyd; Katherine Giuriceo; Timothy Day; William Shrank; Rahul Rajkumar
Journal:  Health Serv Res       Date:  2020-07-27       Impact factor: 3.402

5.  Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan.

Authors:  Derek D Satre; Cynthia I Campbell; Nancy S Gordon; Constance Weisner
Journal:  Int J Psychiatry Med       Date:  2010       Impact factor: 1.210

6.  Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study.

Authors:  Edward W Gregg; Andrew J Karter; Robert B Gerzoff; Monika Safford; Arleen F Brown; Chien-Wen Tseng; Beth Waitzfielder; William H Herman; Carol M Mangione; Joseph V Selby; Theodore J Thompson; R Adams Dudley
Journal:  Med Care       Date:  2010-01       Impact factor: 2.983

7.  Appointment adherence and disparities in outcomes among patients with diabetes.

Authors:  Joel M Schectman; John B Schorling; John D Voss
Journal:  J Gen Intern Med       Date:  2008-07-26       Impact factor: 5.128

8.  Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?

Authors:  Wayne Katon; Joan Russo; Elizabeth H B Lin; Susan R Heckbert; Andy J Karter; Lisa H Williams; Paul Ciechanowski; Evette Ludman; Michael Von Korff
Journal:  Psychosom Med       Date:  2009-10-15       Impact factor: 4.312

Review 9.  Health systems, patients factors, and quality of care for diabetes: a synthesis of findings from the TRIAD study.

Authors: 
Journal:  Diabetes Care       Date:  2010-04       Impact factor: 17.152

10.  Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).

Authors:  Laura N McEwen; Dori Bilik; Susan L Johnson; Jeffrey B Halter; Andrew J Karter; Carol M Mangione; Usha Subramanian; Beth Waitzfelder; Jesse C Crosson; William H Herman
Journal:  Diabetes Care       Date:  2009-02-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.